查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386362

輪狀病毒疫苗市場報告：2030 年趨勢、預測與競爭分析

Rotavirus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

輪狀病毒疫苗的趨勢與預測

預計到 2030 年，全球輪狀病毒疫苗市場預計將達到 179 億美元，2024 年至 2030 年年複合成長率為 10.1%。該市場的主要促進因素是輪狀病毒感染病例和死亡率的增加、醫療保健專業人員和家長對輪狀病毒疫苗益處的認知不斷提高。全球輪狀病毒疫苗市場的未來性充滿希望，醫院/診所、學術和研究市場充滿機會。

輪狀病毒疫苗市場洞察

根據 Lucintel 的預測，Rotarix 預計將在預測期內實現最高成長。

由於對輪狀病毒感染疾病早期檢測和治療的需求不斷增加、醫療基礎設施投資增加以及該地區人口持續成長，預計亞太地區將在預測期內實現最高成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2. 未來哪個細分市場成長較快？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球輪狀病毒疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球輪狀病毒疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 全球輪狀病毒疫苗市場（按類型）
    • 輪轉
    • 旋轉
    • 羅塔文-M1
    • Lanzhou lamb
    • 其他
  • 全球輪狀病毒疫苗市場（依最終用途）
    • 醫院和診所
    • 學術與研究
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球輪狀病毒疫苗市場區域分佈
  • 北美輪狀病毒疫苗市場
  • 歐洲輪狀病毒疫苗市場
  • 亞太地區輪狀病毒疫苗市場
  • 其他區域輪狀病毒疫苗市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按類型分類的全球輪狀病毒疫苗市場成長機會
    • 全球輪狀病毒疫苗市場成長機會（依最終用途）
    • 全球輪狀病毒疫苗市場成長機會（按地區）
  • 全球輪狀病毒疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球輪狀病毒疫苗市場產能擴張
    • 全球輪狀病毒疫苗市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • BIOVIRx
  • Serum Institute of India
  • Merck & Co
  • Bharat Biotech
  • Biological E
  • Bio Farma
  • Novartis
  • GlaxoSmithKline
  • Sanofi
  • Lanzhou Institute of Biologicals Products
簡介目錄

Rotavirus Vaccine Trends and Forecast

The future of the global rotavirus vaccine market looks promising with opportunities in the hospital and clinic, academic, and research markets. The global rotavirus vaccine market is expected to reach an estimated $17.9 billion by 2030 with a CAGR of 10.1% from 2024 to 2030. The major drivers for this market are augmenting cases and mortality of rotavirus infection and rising awareness about the benefits of rotavirus vaccines among healthcare professionals and parents/caregivers.

A more than 150-page report is developed to help in your business decisions.

Rotavirus Vaccine by Segment

The study includes a forecast for the global rotavirus vaccine by type, end use, and region.

Rotavirus Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Rotarix
  • Rotateq
  • Rotavin-M1
  • Lanzhou Lamb
  • Others

Rotavirus Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Clinics
  • Academic and Research
  • Others

Rotavirus Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Rotavirus Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rotavirus vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rotavirus vaccine companies profiled in this report include-

  • Biovirx
  • Serum Institute of India
  • Merck & Co
  • Bharat Biotech
  • Biological E
  • Bio Farma
  • Novartis
  • Glaxosmithkline
  • Sanofi
  • Lanzhou Institute of Biologicals Products

Rotavirus Vaccine Market Insights

Lucintel forecasts that rotarix is expected to witness highest growth over the forecast period.

APAC is expected to witness highest growth over the forecast period due to growing demand for early detection and treatment of rotavirus infections, rising investment in healthcare infrastructural development, and continuous population growth in the region.

Features of the Global Rotavirus Vaccine Market

Market Size Estimates: Rotavirus vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rotavirus vaccine market size by type, end use, and region in terms of value ($B).

Regional Analysis: Rotavirus vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the rotavirus vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rotavirus vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rotavirus vaccine market size?

Answer: The global rotavirus vaccine market is expected to reach an estimated $17.9 billion by 2030.

Q.2 What is the growth forecast for rotavirus vaccine market?

Answer: The global rotavirus vaccine market is expected to grow with a CAGR of 10.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rotavirus vaccine market?

Answer: The major drivers for this market are augmenting cases and mortality of rotavirus infection and rising awareness about the benefits of rotavirus vaccines among healthcare professionals and parents/caregivers.

Q4. What are the major segments for rotavirus vaccine market?

Answer: The future of the rotavirus vaccine market looks promising with opportunities in the hospital and clinic, academic, and research markets.

Q5. Who are the key rotavirus vaccine market companies?

Answer: Some of the key rotavirus vaccine companies are as follows:

  • Biovirx
  • Serum Institute of India
  • Merck & Co
  • Bharat Biotech
  • Biological E
  • Bio Farma
  • Novartis
  • Glaxosmithkline
  • Sanofi
  • Lanzhou Institute of Biologicals Products

Q6. Which rotavirus vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that rotarix is expected to witness highest growth over the forecast period.

Q7. In rotavirus vaccine market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing demand for early detection and treatment of rotavirus infections, rising investment in healthcare infrastructural development, and continuous population growth in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the rotavirus vaccine market by type (rotarix, rotateq, rotavin-m1, lanzhou lamb, and others), end use (hospitals and clinics, academic and research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rotavirus Vaccine Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Rotavirus Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Rotavirus Vaccine Market by Type
    • 3.3.1: Rotarix
    • 3.3.2: RotaTeq
    • 3.3.3: Rotavin-M1
    • 3.3.4: Lanzhou lamb
    • 3.3.5: Others
  • 3.4: Global Rotavirus Vaccine Market by End Use
    • 3.4.1: Hospitals and Clinics
    • 3.4.2: Academic and Research
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Rotavirus Vaccine Market by Region
  • 4.2: North American Rotavirus Vaccine Market
    • 4.2.2: North American Rotavirus Vaccine Market by End Use: Hospitals and Clinics, Academic and Research, and Others
  • 4.3: European Rotavirus Vaccine Market
    • 4.3.1: European Rotavirus Vaccine Market by Type: Rotarix, RotaTeq, Rotavin-M1, Lanzhou lamb, and Others
    • 4.3.2: European Rotavirus Vaccine Market by End Use: Hospitals and Clinics, Academic and Research, and Others
  • 4.4: APAC Rotavirus Vaccine Market
    • 4.4.1: APAC Rotavirus Vaccine Market by Type: Rotarix, RotaTeq, Rotavin-M1, Lanzhou lamb, and Others
    • 4.4.2: APAC Rotavirus Vaccine Market by End Use: Hospitals and Clinics, Academic and Research, and Others
  • 4.5: ROW Rotavirus Vaccine Market
    • 4.5.1: ROW Rotavirus Vaccine Market by Type: Rotarix, RotaTeq, Rotavin-M1, Lanzhou lamb, and Others
    • 4.5.2: ROW Rotavirus Vaccine Market by End Use: Hospitals and Clinics, Academic and Research, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Rotavirus Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Rotavirus Vaccine Market by End Use
    • 6.1.3: Growth Opportunities for the Global Rotavirus Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Rotavirus Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Rotavirus Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rotavirus Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: BIOVIRx
  • 7.2: Serum Institute of India
  • 7.3: Merck & Co
  • 7.4: Bharat Biotech
  • 7.5: Biological E
  • 7.6: Bio Farma
  • 7.7: Novartis
  • 7.8: GlaxoSmithKline
  • 7.9: Sanofi
  • 7.10: Lanzhou Institute of Biologicals Products